Kunal Sindhu, M.D.
NPI 1255862017 · Radiation Oncology Physician · New York, NY
Enrolled with Medicare as Practitioner - Radiation Oncology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1255862017
- Entity type
- Individual
- Primary specialty
- Radiation Oncology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- 316962-01 (NY)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
9 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
1,070 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Ct Guidance for Insertion of Radiation Therapy Fields77014 | 480 | $48 |
| Calculation of Radiation Therapy Dose77300 | 182 | $35 |
| Radiation Treatment Management, 5 Treatment Sessions77427 | 97 | $210 |
| Design and Construction of Complex Radiation Treatment Device77334 | 70 | $66 |
| Complex Radiation Therapy Planning77263 | 50 | $184 |
| High Precision Radiation Therapy Planning77301 | 39 | $454 |
| Design and Construction of Radiation Treatment Device for High Precision Radiation Therapy |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 3 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Lidocaine Hclbrand: Lidocaine Hcl Viscous | 38 | 13 |
| Mometasone Furoate | 25 | 15 |
| Oxycodone Hcl | 17 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Practice location
Mailing address
Registry dates
- Enumerated
- 2017-03-23
- Last updated
- 2024-05-28
- Certified
- 2022-09-16
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.